Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis

Author:

Tsukamoto Shuichi1ORCID,Koma Yu-ichiro1ORCID,Kitamura Yu12,Tanigawa Kohei12,Azumi Yuki12,Miyako Shoji12ORCID,Urakami Satoshi13,Hosono Masayoshi2,Kodama Takayuki1ORCID,Nishio Mari1ORCID,Shigeoka Manabu1,Yokozaki Hiroshi1ORCID

Affiliation:

1. Division of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

2. Division of Gastro-Intestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

3. Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

Abstract

Tumor-associated macrophages (TAMs) contribute to disease progression in various cancers, including esophageal squamous cell carcinoma (ESCC). We have previously used an indirect co-culture system between ESCC cell lines and macrophages to analyze their interactions. Recently, we established a direct co-culture system to closely simulate actual ESCC cell-TAM contact. We found that matrix metalloproteinase 9 (MMP9) was induced in ESCC cells by direct co-culture with TAMs, not by indirect co-culture. MMP9 was associated with ESCC cell migration and invasion, and its expression was controlled by the Stat3 signaling pathway in vitro. Immunohistochemical analyses revealed that MMP9 expression in cancer cells at the invasive front (“cancer cell MMP9”) was related to high infiltration of CD204 positive M2-like TAMs (p < 0.001) and was associated with worse overall and disease-free survival of patients (p = 0.036 and p = 0.038, respectively). Furthermore, cancer cell MMP9 was an independent prognostic factor for disease-free survival. Notably, MMP9 expression in cancer stroma was not associated with any clinicopathological factors or patient prognoses. Our results suggest that close interaction with TAMs infiltrating in cancer stroma or cancer nests induces MMP9 expression in ESCC cells, equipping them with more malignant features.

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference53 articles.

1. Sheikh, M., Roshandel, G., McCormack, V., and Malekzadeh, R. (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers, 15.

2. Cancer Statistics (2023, February 24). Cancer Information Service, National Cancer Center, Japan (National Cancer Registry, Ministry of Health, Labour and Welfare). Available online: https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a14.

3. Comprehensive registry of esophageal cancer in Japan, 2015;Watanabe;Esophagus Off. J. Jpn. Esophageal Soc.,2023

4. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma;Shimada;Surgery,2003

5. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy;Komohara;Adv. Drug Deliv. Rev.,2016

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3